Cite Filings / AMLX / 0000899243-23-009164

Feed Companies Filings Check

Sign in

3

Initial Statement of Ownership

Amylyx Pharmaceuticals, Inc. Filed 2023-03-20 Acc 0000899243-23-009164

Documents 1

3 Initial Statement of Ownership , xslF345X02/doc3.xml

Around this filing

2023-11-29 3 Initial Statement of Ownership
2023-03-20 4 Co-Chief Executive Officer sold 100,000 shares at an average $31.86 ($3,186,236)
2023-03-20 4 Chief Commercial Officer acquired 18,333 shares (grant or award)
2023-03-20 4 Director sold 35,000 shares at an average $31.89 ($1,116,072)
2023-03-20 4 Director bought 1,000 shares at $31.99 ($31,990)
2023-03-20 3 Initial Statement of Ownership
2022-05-05 3 Initial Statement of Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslF345X02/doc3.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…